Organization Profile

You just read:

Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis

News provided by

Eli Lilly and Company

Nov 07, 2015, 19:30 ET